Promises and Perils of Molecularly Targeted Therapeutics in Anaplastic Thyroid Cancer
- PMID: 27288466
- DOI: 10.1200/JOP.2016.013144
Promises and Perils of Molecularly Targeted Therapeutics in Anaplastic Thyroid Cancer
Comment on
-
Anaplastic Thyroid Carcinoma: Treatment in the Age of Molecular Targeted Therapy.J Oncol Pract. 2016 Jun;12(6):511-8. doi: 10.1200/JOP.2016.012013. J Oncol Pract. 2016. PMID: 27288464 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
